Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health

Annual Review of Food Science and Technology
Susan A Joyce, Cormac G M Gahan

Abstract

Bile acids have emerged as important signaling molecules in the host, as they interact either locally or systemically with specific cellular receptors, in particular the farnesoid X receptor (FXR) and TGR5. These signaling functions influence systemic lipid and cholesterol metabolism, energy metabolism, immune homeostasis, and intestinal electrolyte balance. Through defined enzymatic activities, the gut microbiota can significantly modify the signaling properties of bile acids and therefore can have an impact upon host health. Alterations to the gut microbiota that influence bile acid metabolism are associated with metabolic disease, obesity, diarrhea, inflammatory bowel disease (IBD), Clostridium difficile infection, colorectal cancer, and hepatocellular carcinoma. Here, we examine the regulation of this gut-microbiota-liver axis in the context of bile acid metabolism and indicate how this pathway represents an important target for the development of new nutraceutical (diet and/or probiotics) and targeted pharmaceutical interventions.

References

Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Aug 1, 1997·Journal of Gastroenterology·N OhkohchiR Ohi
Jun 9, 2000·Annual Review of Physiology·K E Barrett, S J Keely
Apr 11, 2003·The Journal of Biological Chemistry·Erik G LundDavid W Russell
Nov 18, 2003·Journal of Lipid Research·Nariyasu ManoJunichi Goto
Oct 14, 2004·JAMA : the Journal of the American Medical Association·Henry BuchwaldKaren Schoelles
Aug 17, 2005·FEMS Microbiology Reviews·Máire BegleyColin Hill
Sep 28, 2005·Journal of Lipid Research·Elyisha A HannimanChristopher J Sinal
Nov 22, 2005·Journal of Lipid Research·Jason M RidlonPhillip B Hylemon
Dec 20, 2005·Neurochemical Research·Jan Albrecht, Arne Schousboe
Jan 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yanqiao ZhangPeter A Edwards
Jan 27, 2006·Nature·John D Baxter, Paul Webb
Feb 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Takeshi InagakiSteven A Kliewer
Mar 7, 2006·Applied and Environmental Microbiology·Máire BegleyCormac G M Gahan
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Alan F Hofmann, Lars Eckmann
Mar 25, 2006·The Journal of Clinical Investigation·Ke MaDavid D Moore
Jul 11, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Yanqiao ZhangPeter A Edwards
Apr 4, 2007·Pharmaceutical Research·Waddah A Alrefai, Ravinder K Gill
Aug 10, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hannah JacksonJoe West
Aug 24, 2007·The New England Journal of Medicine·Lars SjöströmUNKNOWN Swedish Obese Subjects Study
Feb 5, 2008·Journal of Bacteriology·Joseph A Sorg, Abraham L Sonenshein
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brian V JonesJulian R Marchesi
Nov 26, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Andrea MencarelliStefano Fiorucci
Feb 21, 2009·World Journal of Gastroenterology : WJG·Maria J MonteJose Vazquez-Tato
Apr 7, 2009·Journal of Lipid Research·John Y L Chiang
May 12, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Julian R F WaltersCarel W le Roux
Sep 22, 2009·The Journal of Pharmacology and Experimental Therapeutics·Masaaki MiyataYasushi Yamazoe
Nov 3, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrea MencarelliStefano Fiorucci
Apr 17, 2010·Current Gerontology and Geriatrics Research·Romina M Uranga, Jeffrey N Keller
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jonathan R SwannElaine Holmes
Aug 16, 2011·Gastroenterology·K B M Saiful IslamAtsushi Yokota

❮ Previous
Next ❯

Citations

May 19, 2016·Future Microbiology·Wen-Ting XuNong-Hua Lu
Jul 1, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Juan P ArabMichael Trauner
Jun 28, 2016·Molecular Nutrition & Food Research·Kyle T Dolan, Eugene B Chang
Oct 23, 2016·Biochimica Et Biophysica Acta. General Subjects·Deepak ChandSureshkumar Ramasamy
Feb 12, 2017·International Journal of Cancer. Journal International Du Cancer·Hailong CaoBangmao Wang
Jun 13, 2017·Molecular Aspects of Medicine·Sarah L LongSusan A Joyce
Jan 5, 2018·Diabetology & Metabolic Syndrome·Paul M RyanNoel M Caplice
Dec 28, 2018·Gut Microbes·Solenne MarionRizlan Bernier-Latmani
Jul 11, 2019·International Journal of Cancer. Journal International Du Cancer·Tianyu LiuHailong Cao
Oct 16, 2016·American Journal of Physiology. Gastrointestinal and Liver Physiology·Dervla O'Malley
Aug 29, 2019·Physiological Reviews·John F CryanTimothy G Dinan
Feb 19, 2020·Expert Review of Endocrinology & Metabolism·Moritz V WarmbrunnMax Nieuwdorp
May 11, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Natalia K LajczakStephen J Keely
Feb 28, 2017·Nutrition & Metabolism·Lidiya G DimovaUwe J F Tietge
May 25, 2018·Lipids in Health and Disease·Yanan LiuDong Liu
Dec 21, 2016·Current Opinion in Clinical Nutrition and Metabolic Care·Monika A KrezalekMichael Morowitz
Jun 6, 2017·Frontiers in Physiology·Allison Clark, Núria Mach
Sep 27, 2018·Frontiers in Immunology·Mathangi Janakiraman, Gurumoorthy Krishnamoorthy
May 5, 2018·Protein & Cell·Zeneng Wang, Yongzhong Zhao
Jun 1, 2018·MSphere·Sarah O'FlahertyRodolphe Barrangou
Jan 26, 2020·Scientific Reports·Roberta PreteSusan A Joyce
Dec 9, 2020·Digestive Diseases and Sciences·Stefano FiorucciMichele Biagioli
May 22, 2020·Brain Research Bulletin·Junfang WuYulan Wang
Dec 15, 2020·Chembiochem : a European Journal of Chemical Biology·Kristoffer R BrandvoldAaron T Wright

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
gastric bypass

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Annual Review of Food Science and Technology
C F WilliamsG R Gibson
Annual Review of Genetics
Sophie Yurist-DoutschB Brett Finlay
Annual Review of Physiology
Asim Mandal, David B Mount
Annual Review of Food Science and Technology
Joran VerspreetChristophe M Courtin
© 2022 Meta ULC. All rights reserved